학술논문
A double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor as an adjunct to induction and consolidation therapy for patients with acute myeloid leukemia
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
00064971